Get the Stockscreener App
171.56
0.65%
1.10
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Balchem Corp stock is traded at $171.56, with a volume of 62,357.
It is up +0.65% in the last 24 hours and up +3.81% over the past month.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
See More
Previous Close:
$170.46
Open:
$172.06
24h Volume:
62,357
Relative Volume:
0.24
Market Cap:
$5.47B
Revenue:
$1.06B
Net Income/Loss:
$158.08M
P/E Ratio:
35.24
EPS:
4.8687
Net Cash Flow:
$175.98M
1W Performance:
+1.74%
1M Performance:
+3.81%
6M Performance:
-1.68%
1Y Performance:
+19.45%
1-Day Range:
$171.12
$174.29
1-Week Range:
$166.15
$171.06
52-Week Range:
$140.70
$183.90
Balchem Corp Stock (BCPC) Company Profile
Name
Balchem Corp
Sector
Industry
Phone
(845) 326-5600
Address
5 PARAGON DRIVE, MONTVALE, NY
Compare BCPC vs LIN, SHW, ECL, APD, PPG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCPC
Balchem Corp
|
171.56 | 5.47B | 1.06B | 158.08M | 175.98M | 4.8687 |
LIN
Linde Plc
|
494.68 | 228.04B | 34.66B | 7.25B | 5.10B | 15.07 |
SHW
Sherwin Williams Co
|
336.92 | 81.79B | 23.94B | 2.60B | 2.91B | 10.42 |
ECL
Ecolab Inc
|
291.56 | 81.73B | 16.45B | 2.12B | 1.87B | 7.3955 |
APD
Air Products Chemicals Inc
|
295.10 | 65.71B | 12.46B | 2.16B | -1.25B | 9.454 |
PPG
Procter Gamble Co
|
107.92 | 23.99B | 16.12B | 1.59B | 1.23B | 6.9799 |
Balchem Corp Stock (BCPC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-22-22 | Upgrade | Sidoti | Neutral → Buy |
| Nov-29-21 | Downgrade | Sidoti | Buy → Neutral |
| Aug-02-21 | Downgrade | Stephens | Overweight → Equal-Weight |
| Feb-22-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-04-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Initiated | Stephens | Equal-Weight |
| Feb-24-20 | Reiterated | H.C. Wainwright | Buy |
| May-06-19 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-21-19 | Initiated | Seaport Global Securities | Neutral |
| Nov-06-18 | Upgrade | Pivotal Research Group | Hold → Buy |
| Oct-16-18 | Upgrade | Sidoti | Neutral → Buy |
| Sep-25-18 | Initiated | H.C. Wainwright | Buy |
| Aug-03-18 | Reiterated | Pivotal Research Group | Hold |
| May-07-18 | Upgrade | Pivotal Research Group | Sell → Hold |
| Nov-04-16 | Downgrade | Pivotal Research Group | Hold → Sell |
| Mar-08-16 | Downgrade | Sidoti | Buy → Neutral |
| Feb-02-16 | Upgrade | Sidoti | Neutral → Buy |
| Apr-02-15 | Initiated | Singular Research | Buy |
| Jul-28-10 | Initiated | DA Davidson | Neutral |
View All
Balchem Corp Stock (BCPC) Latest News
Non-operating income (total) of Balchem Corp – HAN:BL9B - TradingView
Liquidity Mapping Around (BCPC) Price Events - Stock Traders Daily
Balchem Corporation (BCPC) Stock forecasts - Yahoo Finance UK
Balchem (MEX:BCPC) 3-Year RORE % (3-Year Return on Retained Earnings %) : 0.00% (As of Jun. 2026) - GuruFocus
Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026 - GlobeNewswire Inc.
Balchem Corporation Announces Quarterly Conference Call for - GlobeNewswire
Balchem (MEX:BCPC) Shiller PE Ratio - GuruFocus
Balchem (MEX:BCPC) Intrinsic Value: DCF (FCF Based) - GuruFocus
Balchem (MEX:BCPC) Other Current Receivables : MXN0.00 Mil (As of Jun. 2026) - GuruFocus
Balchem (MEX:BCPC) Median PS Value : MXN0.00 (As of Oct. 08, 2026) - GuruFocus
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
Brunswick Corporation Schedules 2026 Third Quarter Earnings Conference Call - GlobeNewswire Inc.
MEX:BCPC Equity-to-Asset: 0.7720 — 14% Above Median - GuruFocus
Balchem (MEX:BCPC) 12-1 Month Momentum % : N/A% (As of Oct. 08, 2026) - GuruFocus
Q1 2023 Balchem Corp Earnings Call Transcript - GuruFocus
Balchem (MEX:BCPC) Financial Strength : 8 (As of Jun. 2026) - GuruFocus
MEX:BCPC FCF Yield %: 3.25 — 10% Above Median - GuruFocus
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
BSP:B2CP34 Piotroski F-Score: 9 — 50% Above Median - GuruFocus
Balchem highlights the power of branded ingredients at SupplySide Global 2026 - Nutraceutical Business Review
Balchem (BSP:B2CP34) Price-to-Owner-Earnings : (As of Oct. 06, 2026) - GuruFocus
BSP:B2CP34 Dividend: Does Balchem Corp Pay a Dividend? - GuruFocus
Balchem (BSP:B2CP34) 10-Year RORE % : 0.00% (As of Jun. 2026) - GuruFocus
BSP:B2CP34 Return-on-Tangible-Equity: 53.62% — 33% Below M - GuruFocus
Balchem Corp (BSP:B2CP34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Balchem Corp (BSP:B2CP34) DCF Valuation - GuruFocus
Balchem Corp (BSP:B2CP34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Balchem (BSP:B2CP34) Issuance of Stock : R$0.00 Mil (TTM As of Jun. 2026) - GuruFocus
BSP:B2CP34 OCF Margin %: 16.45% — 15% Below Median - GuruFocus
BSP:B2CP34 Equity-to-Asset: 0.7720 — 14% Above Median - GuruFocus
Balchem Corp (BSP:B2CP34) Valuation - GuruFocus
Balchem Corp (BSP:B2CP34) Stock News, Headlines & Updates - GuruFocus
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
Balchem Corp (BSP:B2CP34) Stock Earnings Transcripts - GuruFocus
BSP:B2CP34 3-Year Book Growth Rate: 10.40% — 43% Below Med - GuruFocus
Balchem (Nasdaq:BCPC)Stock Analysis - Simply Wall Street
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
Balchem: How DNA methylation supports cellular health for life - SupplySide Supplement Journal
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
Avoiding Lag: Real-Time Signals in (BCPC) Movement - Stock Traders Daily
Net income before discontinued operations of Balchem Corp – HAN:BL9B - tradingview.com
Balchem Corp Revenue Breakdown – HAN:BL9B - tradingview.com
Balchem looks at Asia as its Next Growth Frontier for VitaCholine® and OptiMSM® - Asia Food Beverages
Balchem (BCPC) Stock Looks Below Fair Value At Today’s Price - Yahoo Finance
Most of the shares held directly by Balchem's (BCPC) R&D chief are restricted and vest over time. - Stock Titan
Balchem Corporation (BCPC) Stock forecasts - Yahoo Finance Singapore
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
Balchem (BCPC) Stock Could Be 25% Undervalued On Cash Flow - simplywall.st
Balchem Corporation (BCPC) Stock Forecasts - Yahoo! Finance Canada
Balchem’s Optifolin+ may offer epigenetic health solutions - NutraIngredients.com
Balchem Corp Stock (BCPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Balchem Corp Stock (BCPC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| van Gunsteren Job Leonard | Officer |
Dec 04 '25 |
Proposed Sale |
153.29 |
6,000 |
919,722 |
0 |
| van Gunsteren Job Leonard | SVP and GM, Specialty Products |
Dec 04 '25 |
Option Exercise |
60.85 |
6,000 |
365,100 |
15,446 |
| van Gunsteren Job Leonard | SVP and GM, Specialty Products |
Dec 04 '25 |
Sale |
153.29 |
6,000 |
919,723 |
9,446 |
| Fischer David B | Director |
Dec 03 '25 |
Sale |
153.97 |
8,000 |
1,231,748 |
7,989 |
| Fischer David B | Director |
Dec 03 '25 |
Proposed Sale |
153.91 |
6,000 |
923,458 |
0 |
| Fischer David B | Director |
Dec 03 '25 |
Proposed Sale |
154.20 |
2,000 |
308,400 |
0 |
| Reid Martin Luther | SVP Chief Supply Chain Officer |
Nov 11 '25 |
Sale |
154.44 |
1,200 |
185,328 |
7,391 |
| Reid Martin Luther | Officer |
Nov 11 '25 |
Proposed Sale |
154.44 |
1,200 |
185,328 |
0 |
0.42%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):